Multiple Sclerosis

Dr John Corboy: The Jury Is Still Out on COVID-19 Risk for Patients With MS

November 23rd 2020, 1:00pm


Patients with multiple sclerosis (MS) may not have an increased risk of contracting coronavirus disease 2019 (COVID-19), explained John Corboy, MD, of the University of Colorado Denver, School of Medicine.

Shift to Earlier Treatment, Access to More DMTs Improved Outcomes in Pediatric-Onset MS

November 20th 2020, 8:45pm


The shift to treat patients with pediatric-onset multiple sclerosis (POMS) who are treated earlier with a wider variety of medications has led to better outcomes, according to a recent study.

Dr Ruth Ann Marrie on Comorbidities Affecting MS Treatment Decisions

November 17th 2020, 12:45pm


Ruth Ann Marrie, MD, PhD, director of the Multiple Sclerosis Clinic at the University of Manitoba, discusses how comorbidities affect treatment and options for patients with multiple sclerosis (MS).

Swedish Study Examines Impact of Comorbidities on Cost of MS Over Time

November 13th 2020, 11:25pm


Which types of comorbidities have the greatest impact on direct and indirect costs of multiple sclerosis (MS) over time?

Dr Patricia Coyle on Escalation vs High-Efficacy Induction in MS

November 11th 2020, 9:45pm


Patricia K. Coyle, MD, of Stony Brook University Neurosciences Institute, explains how studies are trying to answer a debate about 2 approaches to treat multiple sclerosis (MS).

Dr Ruth Ann Marrie Discusses Comorbidities in Multiple Sclerosis

November 7th 2020, 12:45pm


Ruth Ann Marrie, MD, PhD, director of the Multiple Sclerosis Clinic at the University of Manitoba, speaks about the overall prevalence of comorbidities in patients with multiple sclerosis (MS).

Adverse Childhood Experiences More Common in MS, Study Says

November 7th 2020, 1:00am


The study sought to determine if 2 specific types of adverse childhood experiences, abuse and neglect, are linked with multiple sclerosis (MS) and other immune-mediated inflammatory diseases.

New Recommendations Open Door a Bit to Stem Cell Transplant for MS

October 31st 2020, 10:00am


The procedure might work best in patients who have had multiple sclerosis (MS) for less than 10 years, the report said.

Dr John Corboy on Probing Patient Quality of Life Off Medication for MS

October 30th 2020, 2:00pm


Quality of life for patients with multiple sclerosis (MS) could be better when they are off medication because they will not have adverse effects related to those medications, said John Corboy, MD, professor of neurology, University of Colorado Denver, School of Medicine.

MS Research Examines PPD, Ozanimod in Pregnancy

October 24th 2020, 9:30pm


Two abstracts presented at a recent multiple sclerosis meeting examined depression in pregnancy and pregnancy outcomes in ozanimod trials.